ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,101.08
0.24%
US Tech 100
21,234.80
-0.12%
Dow Jones
44,473.51
0.72%
Brent Oil
77.375
-1.23%
Bitcoin
105,820.83
2.11%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Galapagos (GLPG) Quote

Galapagos

Galapagos (GLPG)

Galapagos NV
22.78
-0.16
(-0.70%)
Closed January 23 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
22.78
Bid
22.56
Ask
22.90
Volume
189,244
22.12 Day's Range 22.84
22.00 52 Week Range 37.17
Market Cap
1.501B
Previous Close
22.94
Open
22.44
Last Trade
1
@
22.78
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
118,380
Shares Outstanding
65,897,000
Dividend Yield
-
PE Ratio
7.09
Earnings Per Share (EPS)
3.21
Revenue
843.8M
Net Profit
211.7M

About Galapagos

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.glpg.com
Headquarters
Mechelen, Antwerp, Bel
Founded
-
Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker GLPG. The last closing price for Galapagos was 22.94 €. Over the last year, Galapagos shares have traded in a share price range of 22.00 € to 37.17 €.

Galapagos currently has 65,897,000 shares outstanding. The market capitalization of Galapagos is 1.51 € billion. Galapagos has a price to earnings ratio (PE ratio) of 7.09.

Ask ADVFN Intelligence (AI)

GLPG Latest News

More News

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will...

January 08 2025
GlobeNewswire Inc.

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos intends to create a new company with approximately €2.45 billion in cash...

January 08 2025
UK Regulatory

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company...

January 07 2025
UK Regulatory

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on...

January 07 2025
GlobeNewswire Inc.

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Data from the ongoing Phase...

December 07 2024
UK Regulatory

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity and an encouraging safety profile in all NHL subtypes...

December 07 2024
GlobeNewswire Inc.

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell...

November 05 2024
GlobeNewswire Inc.

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in...

November 05 2024
UK Regulatory

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster...

October 30 2024
UK Regulatory

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster strategy.We are committed to addressing the high unmet needs of patients through a...

October 30 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.42-1.8103448275923.223.4222.1210845622.98632179DE
4-3.14-12.114197530925.9231.0822.1216576325.63311786DE
12-2.7-10.596546310825.4831.0822.1211838025.50901486DE
26-2.3-9.170653907525.0831.082210889625.57731699DE
52-12.12-34.727793696334.937.17229459326.86243975DE
156-27.77-54.935707220650.5566.282215520142.0030026DE
260-189.32-89.2597831212212.1252.92227995987.13878189DE

GLPG - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?
The current share price of Galapagos is 22.78 €
How many Galapagos shares are in issue?
Galapagos has 65,897,000 shares in issue
What is the market cap of Galapagos?
The market capitalisation of Galapagos is EUR 1.51B
What is the 1 year trading range for Galapagos share price?
Galapagos has traded in the range of 22.00 € to 37.17 € during the past year
What is the PE ratio of Galapagos?
The price to earnings ratio of Galapagos is 7.09
What is the cash to sales ratio of Galapagos?
The cash to sales ratio of Galapagos is 1.78
What is the reporting currency for Galapagos?
Galapagos reports financial results in EUR
What is the latest annual turnover for Galapagos?
The latest annual turnover of Galapagos is EUR 843.8M
What is the latest annual profit for Galapagos?
The latest annual profit of Galapagos is EUR 211.7M
What is the registered address of Galapagos?
The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800
What is the Galapagos website address?
The website address for Galapagos is www.glpg.com
Which industry sector does Galapagos operate in?
Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALNMRNamR SA
0.48 €
(118.18%)
172.3k
GNROGeNeuro SA
0.224 €
(57.75%)
1.93M
DMSBSDiagnostic Medical Systems
0.007 €
(55.56%)
108.08k
FORSEForsee Power SA
0.736 €
(20.46%)
650.18k
IVAInventiva
2.50 €
(19.05%)
226.8k
MLERHElix Rental Housing Socimi ii SA
2.00 €
(-90.00%)
1
ALCYBCybergun
0.0001 €
(-50.00%)
65.99M
MLOCTOctopus Biosafety
0.148 €
(-35.65%)
10.55k
ALNEVNeovacs
0.3903 €
(-21.77%)
24.06k
ALRPDRapid Nutrition
0.0316 €
(-18.97%)
8.93M
ATOAtos SE
0.0021 €
(0.00%)
465.95M
BCPBanco Comercial Portugues SA
0.5186 €
(1.85%)
73.43M
ALCYBCybergun
0.0001 €
(-50.00%)
65.99M
ALVERVergnet
0.0014 €
(-12.50%)
59.46M
ALMASMastrad
0.0202 €
(-3.81%)
20.52M

Discussion

View Full Feed
Golden Cross Golden Cross 1 minute ago
$WKSP Worksport Stock Forecast & Price Target $1.75
https://marketbeat.com/stocks/NASDAQ/WKSP/forecast/
WKSP
CrashOverride CrashOverride 1 minute ago
Hedge funds definitely want retail to sell on news so they can go long in size but that's not happening for many retail shareholders in Northwest Biotherapeutics. We know the value of DCVax platform technology and we're not giving up shares cheaply. My 30K sell order at $42 reflects the value of n
NWBO
budfoxfun budfoxfun 1 minute ago
Living Mulch is another exciting aspect we’ll explore. This method involves using ground cover that can thrive in indoor settings, helping to suppress weeds, retain moisture, and improve overall soil health. Imagine a cozy indoor space filled with lush, green plants that not only beautify the enviro
SGTM
linkvest linkvest 1 minute ago
Indeed we all would like a few more of these shares. I'm waiting for some money to clear from a transfer I did.
RDAR
sissyjane1 sissyjane1 1 minute ago
late day rally !!!!! green baby
MONI
sundoctor sundoctor 1 minute ago
Why not sell at 0.0002?
TSOI
burner67 burner67 1 minute ago
I think you're right. I saw his name on the filing but it was Joe's home address. I got mixed the F up lol.
BEGI
norisknorewards norisknorewards 2 minutes ago
have that gut feel this ends at .299
NWBO
Mistervane Mistervane 2 minutes ago
Guess you have a few aliases on this board, eh Tom? Pretty obvious it's you trying to pump this garbage so suckers keep paying you free money for nothing.
CBDL
Golden Cross Golden Cross 2 minutes ago
$WKSP Worksport Stock Forecast & Price Target $1.75
https://marketbeat.com/stocks/NASDAQ/WKSP/forecast/
WKSP
jeunke22 jeunke22 2 minutes ago
Nice little video: https://www.youtube.com/watch?v=sbXie768ZZQ
LWLG
koolmc koolmc 2 minutes ago
nice liking the forward event heading into next week see if it follow other cancer stocks out there that had pop today
NYD NYD 2 minutes ago
TY Morg!
BottomBounce BottomBounce 2 minutes ago
$IBM America First Legal sues IBM’s Red Hat over DE&I practices
https://www.hr-brew.com/stories/2024/05/10/america-first-legal-sues-ibm-s-red-hat-over-de-and-i-practices
IBM
Sos28493 Sos28493 2 minutes ago
Do you just copy and paste the same thing over and over?
VPLM
RIGATONI RIGATONI 3 minutes ago
Along with this previous news >>>

SAKL Redeems 15M Shares of Its Common Stock Reducing Issued and Outstanding to 86M


https://www.otcmarkets.com/stock/SAKL/news/SAKL-Redeems-15M-Shares-of-Its-Common-Stock-Reducing-Issued-and-Outstanding-to-86M?id=375332
SAKL
BottomBounce BottomBounce 3 minutes ago
$IBM America First Legal sues IBM’s Red Hat over DE&I practices
https://www.hr-brew.com/stories/2024/05/10/america-first-legal-sues-ibm-s-red-hat-over-de-and-i-practices
IBM
vlispxpert vlispxpert 3 minutes ago
MVIS lol, was looking thru my orders, my gtc sold 1.91...have 30+ stocks, so it got lost in the crowd...gotta love when that happens...congrats if still in

Read post I'm responding to
MVIS
attilathehunt attilathehunt 3 minutes ago
Need 755k more volume o finish the day at 10m.
NWBO
greg19440 greg19440 3 minutes ago
Agreed, this has a signs of MWM’s MO, lol
TGLO
georgie18 georgie18 3 minutes ago
PL...$4.63...🥳

georgie18

Member Level
Re: georgie18 post# 387491

Thursday, January 23, 2025 9:12:05 AM

Post#
388936
of 388978
PL...$4.35...🥳... SAN FRANCISCO--(BUSINESS WIRE)-- Planet Labs PBC
Screech691 Screech691 3 minutes ago
R3VIVE® ODOR CLEANING PRODUCTS
Ren3w® Bio-Cleaning Programs provide eco-friendly cleaning solutions that mimic natural cleaning systems. These programs offer poison-free alternatives for safer cleaning. One of the products, Vim, effectively cleans and sanitizes surfaces. BioLogik harnesses th
SGTM
Myth Myth 3 minutes ago
I'd only take the over on a teaser....but I've been known to be wrong..lol..

I did add some more on Wash + 6, I already had it at +5 1/2..

gl whatever you do, plenty of time yet to ponder on it..

weather is good, that's a plus for the over
georgie18 georgie18 3 minutes ago
PL...$4.63...🥳

georgie18

Member Level
Re: georgie18 post# 387491

Thursday, January 23, 2025 9:12:05 AM

Post#
388936
of 388978
PL...$4.35...🥳... SAN FRANCISCO--(BUSINESS WIRE)-- Planet Labs PBC
PL

Your Recent History

EU
GLPG
Galapagos
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads